Apostolos Tsiachristas
Overview
Explore the profile of Apostolos Tsiachristas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mackenna B, Brown A, Croker R, Walker A, Goldacre B, Tsiachristas A, et al.
Br J Gen Pract
. 2025 Feb;
PMID: 39947663
Background: Many patients receive routine medications for long-term conditions (LTCs). Doctors typically issue repeat prescriptions in one to three month durations, but England currently has no national guidance on the...
2.
Lane J, Edwards R, Babarczy B, Whiteley H, Oruganti V, Rutten-van Molken M, et al.
Front Public Health
. 2025 Feb;
12:1426863.
PMID: 39917535
Background: The prevalence of preventable non-communicable disease (NCD) underpins the need for a life-course and cross-sectoral approach to population health that is grounded in health promotion and disease prevention. European...
3.
Zhou J, Millier A, Aballea S, Francois C, Jin H, Williams R, et al.
Br J Psychiatry
. 2024 Dec;
:1-8.
PMID: 39721946
Background: Previous economic evidence about interventions for schizophrenia is outdated, non-transparent and/or limited to a specific clinical context. Aims: We developed a discrete event simulation (DES) model for estimating the...
4.
Crosland P, Marshall D, Hosseini S, Ho N, Vacher C, Skinner A, et al.
Pharmacoeconomics
. 2024 Oct;
42(12):1301-1315.
PMID: 39354214
Care as usual has failed to stem the tide of mental health challenges in children and young people. Transformed models of care and prevention are required, including targeting the social...
5.
Tsiachristas A, Chan K, Wahome E, Kearns B, Patel P, Lyasheva M, et al.
Eur Heart J Qual Care Clin Outcomes
. 2024 Sep;
PMID: 39341792
Aims: Coronary Computed Tomography Angiography (CCTA) is a first line investigation for chest pain in patients with suspected obstructive coronary artery disease (CAD). However, many acute cardiac events occur in...
6.
Brand F, Bale E, Tsiachristas A, Hawton K
BJPsych Open
. 2024 Sep;
10(5):e155.
PMID: 39295440
Self-poisoning with paracetamol is the most frequently used overdose method in the UK. Psychosocial assessments were conducted by mental health clinicians with 127 consecutive individuals who presented with pure paracetamol...
7.
Gongora-Salazar P, Perera R, Rivero-Arias O, Tsiachristas A
Pharmacoeconomics
. 2024 Jul;
42(10):1145-1159.
PMID: 39085565
Background: Health systems are moving towards value-based care, implementing new care models that allegedly aim beyond patient outcomes. Therefore, a policy and academic debate is underway regarding the definition of...
8.
Westwood M, Armstrong N, Krijkamp E, Perry M, Noake C, Tsiachristas A, et al.
Health Technol Assess
. 2024 Jul;
28(31):1-105.
PMID: 39023142
Background: The CaRi-Heart® device estimates risk of 8-year cardiac death, using a prognostic model, which includes perivascular fat attenuation index, atherosclerotic plaque burden and clinical risk factors. Objectives: To provide...
9.
Chan K, Wahome E, Tsiachristas A, Antonopoulos A, Patel P, Lyasheva M, et al.
Lancet
. 2024 Jun;
403(10444):2606-2618.
PMID: 38823406
Background: Coronary computed tomography angiography (CCTA) is the first line investigation for chest pain, and it is used to guide revascularisation. However, the widespread adoption of CCTA has revealed a...
10.
Lajmi N, Alves-Vasconcelos S, Tsiachristas A, Haworth A, Woods K, Crichton C, et al.
Camb Prism Precis Med
. 2024 May;
2:e4.
PMID: 38699518
The personalised oncology paradigm remains challenging to deliver despite technological advances in genomics-based identification of actionable variants combined with the increasing focus of drug development on these specific targets. To...